Patents by Inventor Kevin Edward Yarasheski

Kevin Edward Yarasheski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for measuring concentrations of biomolecules in biofluids
    Patent number: 10976323
    Abstract: The present invention provides methods for measuring the absolute concentration of Tau, and other protein, peptide fragments and proteoforms in CSF and plasma samples collected from a subject. Such biomolecules may be implicated in one or more neurological and neurodegenerative diseases or disorders. Also provided is a method for determining whether a therapeutic agent affects the CSF or plasma concentration of a central nervous system derived biomolecule. Also provided are kits for performing the methods of the invention.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: April 13, 2021
    Assignee: C2N Diagnostics LLC
    Inventors: Kristopher Michael Kirmess, Kevin Edward Yarasheski, Matthew R. Meyer
  • METHODS FOR MEASURING CONCENTRATIONS OF BIOMOLECULES IN BIOFLUIDS
    Publication number: 20190086422
    Abstract: The present invention provides methods for measuring the absolute concentration of Tau, and other protein, peptide fragments and proteoforms in CSF and plasma samples collected from a subject. Such biomolecules may be implicated in one or more neurological and neurodegenerative diseases or disorders. Also provided is a method for determining whether a therapeutic agent affects the CSF or plasma concentration of a central nervous system derived biomolecule. Also provided are kits for performing the methods of the invention.
    Type: Application
    Filed: February 9, 2018
    Publication date: March 21, 2019
    Inventors: Kristopher Michael Kirmess, Kevin Edward Yarasheski, Matthew R. Meyer